Semaglutide
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
==Discovery== | ==Discovery== | ||
| - | Semaglutide was discovered in an effort to increase the lifetime of a once-a-day medication called Liraglutide. It is derived from the GLP-1 hormone, contains two amino acid sequence changes and a covalently attached lipid. | + | Semaglutide was discovered <ref>PMID:26308095/ref> in an effort to increase the lifetime of a once-a-day medication called Liraglutide. It is derived from the GLP-1 hormone, contains two amino acid sequence changes and a covalently attached lipid. |
==Structure and Receptor Binding== | ==Structure and Receptor Binding== | ||
Revision as of 15:06, 26 October 2024
Semaglutide is an analog of the GLP-1 (glucagon-like peptide-1) hormone. It acts as an agonist to the GLP-1 receptor and is used as drug to manage diabetes. Its use has been growing as a weight-loss medication, and potential benefits across a wide range of diseases is currently studied.
Discovery
Semaglutide was discovered [1]
